Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
19 results
- D3.239 - Trimethoprim-induced drug reaction with eosinophilia and systemic symptoms (DRESS) associated with reactivation of human herpesvirus-7 (HHV-7)
- D3.242 - Desensitization to ampicillin fixed drug eruption. Spotting the solution to fix the heart
- D3.243 - Successful subcutaneous desensitization protocols for Canakinumab, Trastuzumab, and Triptorelin: a case series report
- D3.244 - Diagnosing Drug-Induced Sweet Syndrome With Target-Like Lesions Amidst Malignancy And Infection
D3.245 - Positive HLA-B*13:01 Allele in a Patient with Clinical Diagnosis of Drug Induced Eosinophilia with Systemic Symptoms (DRESS)
- D3.246 - Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) induced by enoxaparin: a case report and allergology work up
- D3.247 - A case report of multiple drug hypersensitivity triggered by DRESS to beta-lactamase inhibitors
- D3.248 - Anaphylactic shock after indocyanine green intracervical administration
- D3.249 - Delayed-Type Drug Allergy Combined with Adverse Drug Reactions
- D3.250 - Macrolide Hypersensitivity: Exploring the Value of Skin and Provocation Tests in a Portuguese Case Series
- D3.251 - Selective Facial Angioedema Induced by Propionic Acids: A Clinical Study of NSAID Idiosyncratic Reactions (Type 3a)
D3.389 - Deep Learning-Based Real-Time Identification of Wheezing in Lung Sounds: Applications in Disease Prediction and Early Intervention
D3.390 - Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)
D3.391 - Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)
D3.392 - What information and education is crucial for people with food allergies?
D3.393 - Daily life with a peanut allergy, as a young adult- an interview study
D3.394 - Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks in Patients from Italy
D3.395 - Evaluation for suspected penicillin allergy - the patient perspective
D3.398 - Food provision experience of inpatients with adverse food reactions in the acute hospital setting
Download the app
The congress at your fingertips
Available on
Download